Lv2
180 积分 2024-09-20 加入
Basis for design and development of platinum(IV) anticancer complexes
2个月前
已完结
Platinum(IV) Prodrug with a Docosahexaenoic Acid Ligand Preferentially Accumulates in Drug-Resistant Cells and Triggers Ferroptosis to Overcome Drug Resistance
2个月前
已完结
Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling
2个月前
已完结
Cellular processing of platinum anticancer drugs
2个月前
已完结
Tumor extracellular pH-sensitive polymeric nanocarrier-grafted platinum(iv) prodrugs for improved intracellular delivery and cytosolic reductive-triggered release
2个月前
已完结
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2个月前
已完结
Spatiotemporally Targeted Polypeptide Nanoantidotes Improve Chemotherapy Tolerance of Cisplatin
2个月前
已完结
Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles
3个月前
已完结
Exploiting Metal-to-Metal Electron Transfer in a Ru(II) Polypyridine–Deferasirox Conjugate for Hypoxic Photodynamic Therapy
3个月前
已完结
Radiotherapy-triggered reduction of platinum-based chemotherapeutic prodrugs in tumours
3个月前
已完结
皖公网安备34019202002308
